Microbial pathogenesis in cystic fibrosis: Pulmonary clearance of mucoid Pseudomonas aeruginosa and inflammation in a mouse model of repeated respiratory challenge

Infection and Immunity

Volumn 66, Issue 1, 1998, Pages 280-288

  Yu, H ^a   Hanes, M ^b   Chrisp, C E ^a   Boucher, J C ^a   Deretic, V ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MACROPHAGE INFLAMMATORY PROTEIN 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL TISSUE; ARTICLE; BRONCHIOLITIS; BRONCHOPNEUMONIA; CYSTIC FIBROSIS; HISTOPATHOLOGY; LUNG CLEARANCE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

EID: 0031976051     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.1.280-288.1998     Document Type: Article

References (55)

1. Barth, A. L., and T. L. Pitt. 1995. Auxotrophic variants of Pseudomonas aeruginosa are selected from prototrophic wild-type strains in respiratory infections in patients with cystic fibrosis. J. Clin. Microbiol. 33:37-40.
2. Bayer, A. S., D. P. Speert, S. Park, J. Tu, M. Witt, C. C. Nast, and D. C, Norman. 1991. Functional role of mucoid exopolysaccharide (alginate) in antibiotic-induced and polymorphonuclear leukocyte-mediated killing of Pseudomonas aeruginosa. Infect. Immun. 59:302-308.
3. Bermudez, E. L., and L. S. Young. 1988. Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex. J. Immunol. 140:3006-3013.
4. Biwersi, J., and A. S. Vcrkman. 1994. Functions of CFTR other than as a plasma membrane chloride channel, p. 155-171. In J. A. Dodge, D. J. H. Brock, and J. H. Widdicombe (ed.), Cystic fibrosis-current topics, vol. 2. John Wilcy & Sons Ltd., Chichester, England.
5. Blackwood, L. L., and J. E. Pennington. 1981. Influence of mucoid coating on clearance of Pseudomonas aeruginosa from lungs. Infect. Immun. 32:443-448.
6. Bonfield, T. L., J. R. Panuska, M. W. Konstan, K. A. Hillard, J. B. Hillard, H. Ghnaim, and M. Berger. 1995. Inflammatory cytokines in cystic fibrosis lungs. Am. J. Respir. Crit. Care Mcd. 152:2111-2118.
7. Boucher, J. C, H. Yu, M. H. Mudd, and V. Deretic. 1997. Mucoid Pseudomonas aeruginosa in cystie fibrosis: characterization of nine mutations in clinical isolates and analysis of clearance in a mouse model of respiratory infection. Infect. Immun. 65:3838-3846.
8. Cash, H. A., D. E. Woods, B. McCullough, W. G. Johanson, and J. A. Bass. 1979. A rat model of chronic respiratory infection with Pseudomonas aeruginosa. Am. Rev. Respir. Dis. 119:453-459.
9. Collins, F. S. 1992. Cystic fibrosis: molecular biology and therapeutic implications. Science 256:774-779.
10. Cryz, S. J., Jr., E. Furer, and R. Germanier. 1983. Simple model for the study of Pseudomonas aeruginosa infections in leukopcnic mice. Infect. Immun. 39:1067-1071.
11. Datidson, D. J., J. R. Dorin, G. McLachlan, V. Ranaldi, D. Lamb, C. Doherty, J. Govan, and D. J. Porteous. 1995. Lung disease in the cystic fibrosis mouse exposed to bacterial pathogens. Nat. Genet. 9:351-357.
12. Doggett, R. G., G. M. Harrison, R. N. Stillwell, and E. S. Wallis. 1966. An atypical Pseudomonas aeruginosa associated with cystic fibrosis of the pancreas. J. Pediatr. 68:215-221.
13. Fiorentino, D. F., A. Zlotnik, T. R. Mosmann, M. Howard, and A. O'Garra. 1991. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147:3815-3822.
14. Fyfe, J. A. M., and J. R. W. Govan. 1980. Alginate synthesis in mucoid Pseudomonas aeruginosa: a chromosomal locus involved in control. J. Gen. Microbiol. 119:443-450.
15. Gerard, C., C. Bruyns, A. Marchant, D. Abramowicz, A. Vandenabeele, A. Delraux, W. Fiers, M. Goldman, and T. Velu. 1993. Interleukin-10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J. Exp. Med. 177:547-550.
16. Goldman, M. J., G. M. Anderson, E. D. Stolzenberg, U. P. Kari, M. Zasloff, and J. M. Wilson. 1997. Human β-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 88:553-560.
17. Govan, J. R. W., and V. Deretic. 1996. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol. Rev. 60:539-574.
18. Govan, J. R. W., J. A. M. Fyfe, and N. R. Baker. 1983. Heterogeneity and reduction in pulmonary clearance of mucoid Pseudomonas aeruginosa. Rev. Infect. Dis. 5:S874-S879.
19. Govan, J. R. W., and J. W. Nelson. 1992. Microbiology of lung infection in cystic fibrosis. Br. Mod. Bull. 48:912-930.
20. Greenberger, M. J., R. M. Strieter, S. L. Kunkel, J. M. Danforth, L. L. Laichalk, D. C. McGillicuddy, and T. J. Standiford. 1996. Neutralization of macrophage inflammatory protein-2 attenuates neutrophil recruitment and bacterial clearance in murine Klebsiella pneumonia. J. Infect. Dis. 173:159-165.
21. Hatano, K., J. B. Goldberg, and G. B. Pier. 1995. Biologic activities of antibodies to the neutral-polysaccharide component of the Pseudomonas aeruginosa lipopolysaccharide are blocked by O side chains and mucoid exopolysaccharide (alginate). Infect. Immun. 63:21-26.
22. Holloway, B. W. 1955. Genetic recombination in Pseudomonas aeruginosa. J. Gen. Microbiol. 13:572-581.
23. Howard, M., T. Muchamuel, S. Andrade, and S. Menon. 1993. Interleukin-10 protects mice from lethal endotoxemia. J. Exp. Med. 177:1205-1208.
24. Khan, T. Z., J. S. Wagener, T. Best, J. Martinez, F. J. Accurso, and D. W. H. Riches. 1995. Early pulmonary inflammation in infants with cystic fibrosis. Am. J. Respir. Crit. Care Med. 151:1075-1082.
25. Koch, C., and N. Hoiby. 1993. Pathogenesis of cystic fibrosis. Lancet 341:1065-1069.
26. Kuhn, R., J. Lohler, D. Rennick, K. Rajewsky, and W. Muller. 1993. Inter-leukin-10-deficient mice develop chronic enterocolitis. Cell 75:263-274.
27. Lam, J., R. Chan, K. Lam, and J. W. Costerton. 1980. Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis. Infect. Immun. 28:546-556.
28. Learn, D. B., E. P. Brestel, and S. Seetharama. 1987. Hypochlorite seavenging by Pseudomonas aeruginosa alginate. Infect. Immun. 55:1813-1818.
29. Mahenthiralingam, E., M. E. Campbell, and D. P. Speert. 1994. Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis. Infect. Immun. 62:596-605.
30. Martin, D. W., M. J. Schurr, M. H. Mudd, and V. Deretic. 1993. Differentiation of Pseudomonas aeruginosa into the alginate-producing form: inactivation of mucB causes conversion to mucoidy. Mol. Microbiol. 9:497-506.
31. Martin, D. W., M. J. Sehurr, M. H. Mudd, J. R. W. Govan, B. W. Holloway, and V. Deretic. 1993. Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients. Proc. Natl. Acad. Sci. USA 90:8377-8381.
32. Moore, K. W., A. O'Garra, R. de Waal Malefyt, P. Vieira, and T. R. Mosmann. 1992. Interleukin-10. Annu. Rev. Immunol. 11:165-190.
33. Morissette, C., C. Francoeur, C. Darmond-Zwaig, and F. Gervais. 1996. Lung phagocyte bactericidal function in strains of mice resistant and susceptible to Pseudomonas aeruginosa. Infect. Immun. 64:4984-4992.
34. Mulligan, M. S., A. A. Vaporeiyan, M. Miyasaka, T. Tamatani, and P. A. Ward. 1993. Tumor necrosis factor regulates in vivo intrapulmonary expression of ICAM-1. Am. J. Pathol. 142:1739-1744.
35. Orme, I. M., and F. M. Collins. 1994. Mouse model of tuberculosis, p. 113-134. In B. R. Bloom (ed.), Tuberculosis: pathogenesis, protection and control. ASM Press, Washington, D.C.
36. Pedersen, S. S. 1992. Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis. APMIS 100(Suppl. 28):1-79.
37. Pedersen, S. S., N. Hoiby, F. Espersen, and C. Koch. 1992. Role of alginate in infection with mucoid Pseudomonas aeruginosa in cystic fibrosis. Thorax 47:6-13.
38. Pier, B. B., G. Meluleni, and E. Neuger. 1992. A murine model of chronic mucosal colonization by Pseudomonas aeruginosa. Infect. Immun. 60:4768-4776.
39. Pier, G. B., M. Grout, T. S. Zaidi, J. C. Olsen, L. G. Johnson, J. R. Yankaska, and J. B. Goldberg. 1996. Role of mutant CFTR in hypersusceptibility of. cystic fibrosis patients to lung infections. Science 271:64-67.
40. Pier, G. B., J. M. Saunders, P. Ames, M. S. Edwards, H. Auerbach, J. Goldfarb, D. P. Speert, and S. Hurwitch. 1987. Opsonophagocytic killing antibody to Pseudomonas aeruginosa mucoid exopolysaccharidc in older noncolonized patients with cystic fibrosis. N. Engl. J. Med. 317:793-798.
41. Pier, G. B., G. J. Small, and H. B. Warren. 1990. Protection against mucoid Pseudomonas aeruginosa in rodent models of endobronchial infections. Science 249:537-540.
42. Schall, T. J. 1994. The chemokines, p. 419-460. In A. W. Thomson (ed.), The cytokine handbook, 2nd ed. Academic Press, San Diego, Calif.
43. Schmal, H., T. P. Shanley, M. L. Jones, H. P. Friedl, and P. A. Ward. 1996. Role for macrophage inflammatory protein-2 in lipopolysaccharide-induced lung injury in rats. J. Immunol. 156:1963-1972.
44. Schurr, M. J., D. W. Martin, M. H. Mudd, and V. Deretic. 1994. Gene cluster controlling conversion to alginate-overproducing phenotype in Pseudomonas aeruginosa: functional analysis in a heterologous host and role in the instability of mucoidy. J. Bacteriol. 176:3375-3382.
45. Simpson, J. A., S. E. Smith, and R. T. Dean. 1989. Scavenging by alginate of free radicals released by macrophages. Free Radical Biol. Med. 6:347-353.
46. Smith, J. J., S. M. Trails, E. P. Greenberg, and M. J. Welsh. 1996. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 85:1-20.
47. Sordelli, D. O., V. E. Garcia, C. M. Cerequetti, P. A. Fontan, and A. M. Hooke. 1992. Intranasal immunization with temperature sensitive mutants protects granulocytopenic mice from lethal pulmonary challenge with Pseudomonas aeruginosa. Curr. Microbiol. 24:9-14.
48. Speert, D. P. 1994. Pseudomonas aeruginosa infections in patients with cystic fibrosis, p. 183-236. In A. L. Baltch and R. P. Smith (ed.), Pseudomonas aeruginosa infections and treatment. Marcel Dekker, Inc., New York, N.Y.
49. Starke, J. R., ,M. S. Edwards, C. Langston, and C. J. Baker. 1987. A mouse model of chronic pulmonary infection with Pseudomonas aeruginosa and Pseudomonas cepacia. Pediatr. Res. 22:698-702.
50. Stieritz, D. D., and I. A. Holander. 1975. Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: description of a burned mouse model. J. Infect. Dis. 131:688-691.
51. Tang, H., M. Kays, and A. Prince. 1995. Role of Pseudomonas aeruginosa pili in acute pulmonary infection. Infect. Immun. 63:1278-1285.
52. Welsh, M. J., L.-C. Tsui, T. F. Boat, and A. L. Beaudet. 1995. Cystic fibrosis, p. 3799-3876. In C. R. Seriver, A. L. Beaudet, W. S. Sly, and D. Valle (ed.), The metabolic and molecular basis of inherited disease, vol. III. McGraw-Hill, Inc., New York, N.Y.
53. Woods, D. E., P. A. Sokol, L. E. Brjan, D. G. Storey, S. J. Mattingly, H. J. Vogel, and H. Ceri. 1991. In vivo regulation of virulence of Pseudomonas aeruginosa associated with genetic rearrangement. J. Infect. Dis. 163:143-149.
54. Yu, H., M. J. Schurr, J. C. Boucher, J. M. Martinez-Salazar, D. W. Martin, and V. Deretic. 1996. Molecular mechanism of conversion to mucoidy in Pseudomonas aeruginosa, p. 384-397. In S. Silver, T. Nakazowa, and D. Haas (ed.), Molecular biology of pseudomonads. ASM Press, Washington, D.C.
55. Zar, H., L. Saiman, L. Quittell, and A. Prince. 1995. Binding of Pseudomonas aeruginosa to respiratory epithelial cells from patients with various mutations in the cystic fibrosis transmembrane regulator. J. Pediatr. 126:230-233.